Please login to the form below

Not currently logged in

James D'Arecca joins Actavis

Moves from Bausch & Lomb to take up accounting role

James D'Arecca has moved from eyecare firm Bausch & Lomb to join generic company Actavis as its new chief accounting officer.

He served in a similar role at Bausch & Lomb and in his new position will report to Actavis' chief financial officer R Todd Joyce.

Prior to Bausch & Lomb, he worked for Merck & Co, where he served as executive director and business development controller.

In this role, he was the primary liaison between the controller's organisation and the business development and corporate licensing functions.

Prior to joining Merck, D'Arecca was executive director and assistant controller at Schering-Plough, which Merck acquired in 2009.

His career to date has also included 13 years with PricewaterhouseCoopers, where his industry focus was on pharmaceuticals, medical devices and consumer products.

20th August 2013

From: Sales



Featured jobs

Subscribe to our email news alerts


Add my company
Publicis Resolute

Publicis Life Brands Resolute provides real-life practical solutions to your issues, without fuss or fluff. We are an experienced team...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...